The latest Pharmaceutical and Healthcare disease pipeline guide Liver Fibrosis - Pipeline Review, H2 2017, provides an overview of the Liver Fibrosis (Gastrointestinal) pipeline landscape.
Liver fibrosis is a scarring process which results in inflammation and liver cell death. Symptoms include abdominal pain, easy bruising, lack of appetite, nausea, tenderness and enlargement of the liver, weight loss and yellowing of skin and eyes.
Risk factors include age, heavy alcohol consumption, and chronic infection with hepatitis B or C virus and weakened immune system.
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Liver Fibrosis Pipeline Market Review, H2 2017, provides comprehensive information on the therapeutics under development for Liver Fibrosis (Gastrointestinal), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Access this Research Report at www.reportsnreports.com/contacts/d…aspx?name=1192356
The Liver Fibrosis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Liver Fibrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical and Discovery stages are 7, 3, 1, 1, 51 and 9 respectively.
Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 9 and 1 molecules, respectively.
Liver Fibrosis (Gastrointestinal) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.
Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
More Inquire at www.reportsnreports.com/contacts/i…aspx?name=1192356
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
- The pipeline guide provides a snapshot of the global therapeutic landscape of Liver Fibrosis (Gastrointestinal).
- The pipeline guide reviews pipeline therapeutics for Liver Fibrosis (Gastrointestinal) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Liver Fibrosis (Gastrointestinal) therapeutics and enlists all their major and minor projects.
Access this Research Report at www.reportsnreports.com/purchase.aspx?name=1192356
- The pipeline guide evaluates Liver Fibrosis (Gastrointestinal) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Liver Fibrosis (Gastrointestinal).
Table of Contents
Table of Contents
Liver Fibrosis - Overview
Liver Fibrosis - Therapeutics Development
Liver Fibrosis - Therapeutics Assessment
Liver Fibrosis - Companies Involved in Therapeutics Development
Liver Fibrosis - Drug Profiles
Liver Fibrosis - Dormant Projects
Liver Fibrosis - Discontinued Products
Liver Fibrosis - Product Development Milestones